Uroepithelial and nephrotubula toxicity in patients receiving ifosfamide/mesna: Measurement of urinary N-acetyl-β-d-glucosaminidase and β-2-microglobulin

This publication has 20 references indexed in Scilit:

• Nephrotoxicity after ifosfamide.
  Archives of Disease in Childhood, 1990
• Ifosfamide for children with solid tumours
  The Lancet, 1990
• Ifosamide
  JNCI Journal of the National Cancer Institute, 1988
• Ifosfamide-pharmacology, safety and therapeutic potential
  Cancer Treatment Reviews, 1985
• Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity
  European Journal of Cancer and Clinical Oncology, 1984
• Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients
  Cancer Treatment Reviews, 1983
• High-dose ifosfamide and mesna as continuous infusion over five days—a phase I/II trial
  Cancer Treatment Reviews, 1983
• Urinary enzymes, nephrotoxicity and renal disease
  Toxicology, 1982
• PREVENTION OF ISOPHOSPHAMIDE-INDUCED UROTHELIAL TOXICITY WITH 2-MERCAPTOETHANE SULPHONATE SODIUM (MESNUM) IN PATIENTS WITH ADVANCED CARCINOMA
  The Lancet, 1980
• Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of β2-microglobulin, albumin, and total protein
  Journal of Clinical Investigation, 1969